By JK WALL Donald Trump’s proposal to allow the federal Medicare program to negotiate prices with drug companies should be a wake-up call for the pharmaceutical industry. Trump is leading in the polls for the Republican nomination and is even drawing
Read More...
Read the complete post at http://thehealthcareblog.com/blog/2016/01/31/what-trumps-plan-to-negotiate-with-pharma-tells-us-about-the-drug-pricing-controversy/
Posted
Jan 31 2016, 02:31 AM
by
THCB